» Articles » PMID: 25411211

Oncogenic Ras Stimulates Eiger/TNF Exocytosis to Promote Growth

Overview
Journal Development
Specialty Biology
Date 2014 Nov 21
PMID 25411211
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Oncogenic mutations in Ras deregulate cell death and proliferation to cause cancer in a significant number of patients. Although normal Ras signaling during development has been well elucidated in multiple organisms, it is less clear how oncogenic Ras exerts its effects. Furthermore, cancers with oncogenic Ras mutations are aggressive and generally resistant to targeted therapies or chemotherapy. We identified the exocytosis component Sec15 as a synthetic suppressor of oncogenic Ras in an in vivo Drosophila mosaic screen. We found that oncogenic Ras elevates exocytosis and promotes the export of the pro-apoptotic ligand Eiger (Drosophila TNF). This blocks tumor cell death and stimulates overgrowth by activating the JNK-JAK-STAT non-autonomous proliferation signal from the neighboring wild-type cells. Inhibition of Eiger/TNF exocytosis or interfering with the JNK-JAK-STAT non-autonomous proliferation signaling at various steps suppresses oncogenic Ras-mediated overgrowth. Our findings highlight important cell-intrinsic and cell-extrinsic roles of exocytosis during oncogenic growth and provide a new class of synthetic suppressors for targeted therapy approaches.

Citing Articles

Integrins Can Act as Suppressors of Ras-Mediated Oncogenesis in the Wing Disc Epithelium.

Martinez-Abarca Millan A, Martin-Bermudo M Cancers (Basel). 2023; 15(22).

PMID: 38001693 PMC: 10670217. DOI: 10.3390/cancers15225432.


as Model System to Study Ras-Mediated Oncogenesis: The Case of the Tensin Family of Proteins.

Martinez-Abarca Millan A, Soler Beatty J, Valencia Exposito A, Martin-Bermudo M Genes (Basel). 2023; 14(7).

PMID: 37510408 PMC: 10379045. DOI: 10.3390/genes14071502.


Tumor heterogeneity: preclinical models, emerging technologies, and future applications.

Proietto M, Crippa M, Damiani C, Pasquale V, Sacco E, Vanoni M Front Oncol. 2023; 13:1164535.

PMID: 37188201 PMC: 10175698. DOI: 10.3389/fonc.2023.1164535.


Pharmacological or genetic inhibition of hypoxia signaling attenuates oncogenic RAS-induced cancer phenotypes.

Zhu J, Huang X, Fu Y, Wang Y, Zheng P, Liu Y Dis Model Mech. 2021; 15(2).

PMID: 34580712 PMC: 8617310. DOI: 10.1242/dmm.048953.


EGFRAP encodes a new negative regulator of the EGFR acting in both normal and oncogenic EGFR/Ras-driven tissue morphogenesis.

Soler Beatty J, Molnar C, Luque C, de Celis J, Martin-Bermudo M PLoS Genet. 2021; 17(8):e1009738.

PMID: 34411095 PMC: 8407591. DOI: 10.1371/journal.pgen.1009738.


References
1.
Zhang X, Ellis S, Sriratana A, Mitchell C, Rowe T . Sec15 is an effector for the Rab11 GTPase in mammalian cells. J Biol Chem. 2004; 279(41):43027-34. DOI: 10.1074/jbc.M402264200. View

2.
Gerstung M, Eriksson N, Lin J, Vogelstein B, Beerenwinkel N . The temporal order of genetic and pathway alterations in tumorigenesis. PLoS One. 2011; 6(11):e27136. PMC: 3206070. DOI: 10.1371/journal.pone.0027136. View

3.
Cheng K, Lahad J, Kuo W, Lapuk A, Yamada K, Auersperg N . The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers. Nat Med. 2004; 10(11):1251-6. DOI: 10.1038/nm1125. View

4.
Ullrich O, Reinsch S, Urbe S, Zerial M, Parton R . Rab11 regulates recycling through the pericentriolar recycling endosome. J Cell Biol. 1996; 135(4):913-24. PMC: 2133374. DOI: 10.1083/jcb.135.4.913. View

5.
Grindstaff K, Yeaman C, Anandasabapathy N, Hsu S, Rodriguez-Boulan E, Scheller R . Sec6/8 complex is recruited to cell-cell contacts and specifies transport vesicle delivery to the basal-lateral membrane in epithelial cells. Cell. 1998; 93(5):731-40. DOI: 10.1016/s0092-8674(00)81435-x. View